Align Technology | ALGN - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
3M USD 4.89B 1.62B 2026-06
Align Technology USD 864.87M 2.84M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Cardinal Health USD 62.86B 65.69B 2026-06
Charles River Laboratories USD 2.84B 1.96B 2026-06
Cooper Companies USD 1.11B 301.2M 2026-03
CVS Health USD 99.37B 3.62B 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Dexcom USD 990.1M 53.5M 2026-06
Henry Schein USD 3.26B 84M 2026-06
Idexx Laboratories USD 791.02M 12.78M 2026-06
Insulet USD 672M 32.3M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
McKesson USD 103.96B 9.5B 2026-06
Mettler Toledo International USD 739.77M 26.57M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Solventum Corp USD 4.8B 169M 2026-06
Stryker USD 4.8B 118M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Veeva Systems USD 609.84M 19.76M 2026-03
Waters USD 527M 592M 2026-06
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06
Zoetis USD 3.15B 85M 2026-06